| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Revenue | $5.94B | +8.7% |
| Cost of Revenue | $3.31B | +8.3% |
| Gross Profit | $2.63B | +9.3% |
| R&D Expense | $112.9M | +4.9% |
| SG&A Expense | $1.41B | +5.5% |
| Operating Income | $1.10B | +27.1% |
| Pre-tax Income | $1.05B | +31.5% |
| Income Tax | $262.2M | +42.0% |
| Net Income | $782.3M |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.09B | +4.7% |
| Inventory | $631.8M | +8.7% |
| Current Assets | $2.39B | +19.7% |
| Total Assets | $10.74B | +5.8% |
| Current Liabilities | $1.15B | +12.0% |
| Long-term Debt | $1.81B | -5.5% |
| Total Liabilities | $3.54B | +0.3% |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.34B | +16.8% |
| Capital Expenditures | $369.0M | -0.3% |
| Investing Cash Flow | -$512.5M | -231.8% |
| Financing Cash Flow | -$568.2M | +63.9% |
| Free Cash Flow | $972.4M | +25.0% |
| +27.3% |
| EPS (Basic) | $7.97 | +27.7% |
| EPS (Diluted) | $7.93 | +27.9% |
| Stockholders' Equity |
| $7.18B |
| +8.8% |